Alliqua BioMedical
Yardley
About Alliqua BioMedical
Alliqua is a biomedical company focused on the development, manufacturing, and marketing of its own proprietary products, utilizing its existing technology portfolio. The company currently markets its own proprietary brands of wound dressings such as SilverSeal® Hydrogel, an antimicrobial dressing; and Hydress® a moist wound dressing. The company intends to pursue projects in the fields of the active ingredient and transdermal drug delivery, as well as advanced wound care. Alliqua’s core transdermal delivery technology platform is designed to deliver drugs and other beneficial ingredients through the skin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $114.2M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jun 2015)
- Ticker: nasdaq:ALQA
- Website: alliqua.com
- Phone: 215-702-8550
Industries & Categories
Biotechnology, Health Diagnostics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/alliqua-biomedical-3517360 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.